Cost of FISH NZD $508 per Test*
Myeloid Disorders |
Lymphoid/Mature B-cell Neoplasms |
Mature B-cell Neoplasms/Mature T-cell Neoplasms |
Myeloproliferative NeoplasmsBCR/ABL1 rearrangement - t(9;22)Loss of 7q31 and 7q22 Trisomy 8 Trisomy 9 Loss of D13S319/LAMP1 (13q14/13q34) Loss of 20q
|
Adult Acute Lymphoid Leukaemia (ALL)BCR/ABL1 rearrangement - t(9;22)
Hyperdiploidy/near haploidy KMT2A (MLL) rearrangement (11q23) IGH rearrangement (14q32) Loss of 9p (CDKN2A) Deletions of 6q (MYB) NUP98 rearrangements (11p15) (T-ALL) ABL1 amplification (T-ALL) MEF2D rearrangement (1q22) ZNF384 rearrangement (12p13) |
Marginal Zone B-Cell Lymphoma, SplenicMALT1 rearrangement (18q21)Loss of 7q31 and 7q22 Gain of 3q27 Gain of chromosome 12 Loss of TP53 (17p13.1) BCL6 rearrangement (3q27) |
Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangement PanelPDGFRA rearrangement (4q12)PDGFRB rearrangement (5q33) FGFR1 (8p11.2) JAK2 rearrangement (9p24.1) BCR/ABL1 rearrangement- t(9;22) |
Childhood Acute Lymphoid Leukaemia (ALL)KMT2A (MLL) rearrangement (11q23)RUNX1/ETV6 rearrangement- t(12;21) BCR/ABL1 rearrangement- t(9;22) Hyperdiploidy/near haploidy iAMP(21) IGH rearrangement (14q32) Loss of 9p (CDKN2A) Deletions of 6q (MYB) ABL1 amplification (T-ALL) MEF2D rearrangement (1q22) TCF3/PBX1/HLF rearrangements (19p13,1q23,17q22) ZNF384 rearrangement (12p13) |
Lymphoplasmacytic LymphomaIGH rearrangement (14q32)Loss of MYB (6q23) |
Myelodysplastic SyndromeMECOM (EVI1) rearrangement (3q26.2)Monosomy 5 or loss of 5q31 Monosomy 7 or loss of 7q31 and 7q22 Trisomy 8 Loss of 9q Loss of 20q NUP98 rearrangements (11p15) |
Chronic Lymphocytic Leukaemia/Small LymphocyticLymphomaTypical Probe:Loss of TP53 (17p13.1)
Full Panel (available on request)Loss of ATM (11q22.3)
Loss of TP53 (17p13.1) Loss of D13S319/LAMP1 (13q14/13q34) Trisomy 12 Additional Probes Available:IGH/CCND1 rearrangement -t(11;14) to exclude mantle cellIGH rearrangement (14q32) Deletions of 6q (MYB) |
Burkitt LymphomaMYC rearrangement (8q24)MYC/IGH rearrangement - t(8;14) IGK/IGL/MYC rearrangements - t(2;8) or t(8;22) |
Acute Myeloid Leukaemia (AML)MECOM (EVI1) rearrangement (3q26.2)RUNX1T1/RUNX1 rearrangement - t(8;21) PML/RARA rearrangement - t(15;17) RARA rearrangement (17q21) CBFB rearrangement - t(16;16) or inv(16) KMT2A (MLL) rearrangement (11q23) Monosomy 5 or loss of 5q31 Monosomy 7 or loss of 7q31 and 7q22 Loss of 9q NUP98 rearrangements (11p15) DEK/NUP214 rearrangement - t(6;9) |
|
Diffuse Large B-Cell Lymphoma with MYC and BCL2 RearrangementsMYC rearrangement (8q24)BCL2 rearrangement (18q21) BCL6 rearrangement (3q27) IGH rearrangement (14q32) |
Secondary AMLKMT2A (MLL) rearrangement (11q23)Monosomy 5 or loss of 5q31 Monosomy 7 or loss of 7q31 and 7q22 MECOM (EVI1) rearrangement (3q26.2) |
Myeloma/ Plasma Cell LeukaemiaTypical Probe Set:Loss of TP53 (17p13.1)Amplification of 1q21(CKS1B)/deletion of 1p (CDKN2C) IGH rearrangement (14q32) Additional Probes Available:IGH/FGFR3 rearrangement - t(4;14)IGH/MAF rearrangement - t(14;16) IGH/CCND1-XT rearrangement - t(11;14) IGH/MAFB rearrangement - t(14;20) MYC rearrangement (8q24) Loss of 13q14 Hyperdiploidy panel Deletions of 6q (MYB) |
Anaplastic Large Cell LymphomaALK rearrangement - (2p23) |
CMLBCR/ABL1 rearrangement - t(9;22)TP53 - Loss of 17p/i(17)(q10) Trisomy 8 Trisomy 9 MECOM (EVI1) rearrangement (3q26.2) NUP98 rearrangements (11p15) |
Follicular LymphomaBCL2 rearrangement (18q21)BCL6 rearrangement (3q27) MYC rearrangement (8q24) IGH/BCL2 rearrangement - t(14;18) MYC/IGH rearrangement - t(8;14) Deletions of 6q (MYB) |
Adult T-cell Leukaemia/Lymphoma (ATLL)TRA/TRD rearrangement (14q11)TRB rearrangement (7q34) |
Mantle Cell LymphomaIGH/CCND1 rearrangement - t(11;14)CCND2 rearrangement (12p13) |
T-cell Prolymphocytic Leukaemia (T-PLL)TRA/TRD rearrangement (14q11)TRB rearrangement (7q34) |
|
Post Bone Marrow TransplantDonor vs recipient (sex mismatch FISH).FISH for any previously identified abnormality. |
Diffuse Large B-Cell LymphomaBCL2 rearrangement (18q21)BCL6 rearrangement (3q27) MYC rearrangement (8q24) IGH/BCL2 rearrangement - t(14;18) MYC/IGH rearrangement - t(8;14) Deletions of 6q (MYB) Loss of TP53 (17p13.1) IGK/IGL/MYC rearrangements - t(2;8) or t(8;22) |
T-Cell LymphomaTRA/TRD rearrangement (14q11)TRB rearrangement (7q34) |
MALT (Mucosa-Associated Lymphoid Tissue)MALT1 rearrangement (18q21) |
Central Nervous System Tumours |
Soft Tissue Malignancy |
Other |
High-Grade Glioma / Glioblastoma MultiformeLoss of 1p / 19qAmplification of EGFR (7p12) Loss of 9p (CDKN2A) |
Atypical Lipomatous Tumour / Well-Differentiated liposarcomaMDM2 amplification (12q15) |
Breast CancerAmplification of ERBB2 (HER2)(17q11.2-q12) |
Low-Grade Glioma / OligodendrogliomaLoss of 1p / 19qLoss of 9p (CDKN2A) |
Clear Cell Sarcoma / Desmoplastic Small Round CellEWSR1 rearrangement (22q11) |
Gastric CancerAmplification of ERBB2 (HER2)(17q11.2-q12)Amplification of EGFR (7p12) |
MedulloblastomaAmplification of MYC (8q24)Amplification of MYCN (2p24) Imbalance of 17q or i(17q) Loss of 6q |
Dedifferentiated LiposarcomaMDM2 amplification (12q15) |
Germ Cell TumourImbalance of 12p or i(12p) |
MeningiomaLoss of 22Loss of 9p (CDKN2A) |
Ewing's Sarcoma/PNET/Askin's TumourEWSR1 rearrangement (22q12) |
Lung Cancer/AdenocarcinomaAmplification of EGFR (7p12)Amplification of ERBB2 (HER2)(17q11.2-q12) ALK rearrangement (2p23) ROS1 rearrangement (6q22) |
Extraskeletal ChrondrosarcomaEWSR1 rearrangement (22q12) |
Squamous Cell Carcinoma of Head & NeckCCND1 amplification (11q13) |
|
NeuroblastomaAmplification of MYCN (2p24)Loss of 1p Loss of 11q 17p/17q |
|
Uveal MelanomaMonosomy 3Loss of 9p (CDKN2A) |
Inflammatory Myofibroblastic TumourALK rearrangement (2p23) |
Congenital Mesoblastic NephromaEWSR1 rearrangement (22q12) |
|
Myxoid Liposarcomast(12;16)(q13;p11) (DDIT3 rearrangement)EWSR1 rearrangement (22q12) |
Renal Cell Chromophobe / OncocytomaLoss of chromosome 2Loss of chromosome 10 Loss of chromosome 17 |
|
Pleomorphic LiposarcomasMDM2 amplification (12q15) |
Renal Papillary Cell CarcinomaGain of chromosome 7Gain of chromosome 17 |
|
Rhabdomyosarcoma AlveolarFOXO1 rearrangement (13q14) |
Transitional Cell CarcinomaGain of chromosome 7Gain of chromosome 9 Gain of chromosome 17 |
|
Synovial SarcomaSS18 rearrangement (18q11.2) |
X Translocation Renal Cell CarcinomaTFE3 rearrangement (Xp11.2) |
|
Alveolar Soft Part SarcomaTFE3 rearrangement (Xp11.2) |
Nodular FasciitisUSP6 rearrangement (17p13) |
|
Dermatofibrosarcoma protuberans (DFSP)t(17;22) COL1A/PDGFB rearrangement |
Midline carcinomasNUTM1 rearrangement (15q14) |
|
Solitary Fibrous TumourSTAT6 Rearrangement (12q13) |
FISH Tests by Chromosome |
||
Chromosome 11p36 microdeletion syndromeWhole chromosome paint Centromere (D1Z5) Sub-telomeric probes (1p/1q) 1q21.2 microdeletion/microduplication syndromes 1q44 microdeletion syndrome |
Chromosome 22q37 microdeletion (Albright like syndrome)Whole chromosome paint Centromere (D2Z1) Sub-telomeric probes (2p/2q) |
Chromosome 3Whole chromosome paintCentromere (D3Z1) Sub-telomeric probes (3p/3q) |
Chromosome 4Wolf-Hirschorn syndrome (4p16)Whole chromosome paint Centromere (D4Z1) Sub-telomeric probes (4p/4q) |
Chromosome 5Cri-du-Chat syndrome (5p15)Whole chromosome paint Centromere (D5Z2) Sub-telomeric probes (5p/5q) |
Chromosome 6Whole chromosome paintCentromere (D6Z1) Sub-telomeric probes (6p/6q) |
Chromosome 77q11.23 microdeletion (Williams syndrome)/microduplication syndromeWhole chromosome paint Centromere (D7Z1) Sub-telomeric probes (7p/7q) |
Chromosome 88q24 microdeletion(trichorhinophalangeal syndrome) Whole chromosome paint Centromere (D8Z2) Sub-telomeric probes (8p/8q) |
Chromosome 9Whole chromosome paintCentromere (chr 9) Sub-telomeric probes (9p/9q) |
Chromosome 10Whole chromosome paintCentromere (chr 10) Sub-telomeric probes (10p/10q) |
Chromosome 11Whole chromosome paintCentromere (D11Z1) Sub-telomeric probes (11p/11q) |
Chromosome 12Whole chromosome paintCentromere (D12Z3) Sub-telomeric probes (12p/12q) |
Chromosome 1313q14 microdeletion syndrome(Retinoblastoma)Whole chromosome paint Centromere (D13Z1) Sub-telomeric probe (13q) |
Chromosome 14Whole chromosome paintCentromere (D14Z1) Sub-telomeric probe (14q) |
Chromosome 1515q11q13 microdeletion (Prader-Willi/Angelman syndrome)15q13.3 microdeletion/microduplication syndromes Whole chromosome paint Centromere (D15Z1) Sub-telomeric probe (15q) |
Chromosome 1616p11.2 microdeletion/microduplication syndromes16p12.1 microdeletion/microduplication syndromes 16p13.33 microdeletion/microduplication syndromes Whole chromosome paint Centromere (D16Z3) Sub-telomeric probes (16p/16q) |
Chromosome 1717p13.3 microdeletion (isolated lissencephaly and Miller-Dieker syndrome)/microduplication syndrome17p11.2 microdeletion syndrome (Smith-Magenis)/microduplication syndrome (Potocki-Lupski) 17q12 microdeletion/microduplication syndromes 17q21.31 microdeletion/microduplication syndromes 17p13.1 microdeletion syndrome (Li-Fraumeni) Whole chromosome paint Centromere (D17Z1) Sub-telomeric probes (17p/17q) |
Chromosome 18Whole chromosome paintCentromere (D18Z1) Sub-telomeric probes (18p/18q) |
Chromosome 19Whole chromosome paintCentromere (chr 19) Sub-telomeric probes (19p/19q) |
Chromosome 20Whole chromosome paintCentromere (D20Z1) Sub-telomeric probes (20p/20q) |
Chromosome 21Whole chromosome paint21q22.13q22.2 locus specific probe Centromere (chr 21) Sub-telomeric probe (21q) |
Chromosome 2222q11.2 microdeletion (DiGeorge syndrome)/duplication syndromeDistal 22q11.2 microdeletion/duplication syndromes 22q13 microdeletion/microduplication syndromes Whole chromosome paint Centromere (chr 22) Sub-telomeric probe (22q) |
X ChromosomeXp22.3 deletion syndrome (Kallman)Xp22.3 deletion (Steroid Sulfatase deficiency syndrome) Xp22 deletion (SHOX) Centromere (DXZ1) Xq13 XIST Whole chromosome paint Xq26.2 microdeletion (Simpson-Golabi-Behmel syndrome) Sub-telomeric probes (Xp/Xq) M-BAND |
Y ChromosomeYp11.3 (SRY)Whole chromosome paint Centromere (DYZ3) Sub-telomeric probes (Yp/Yq) |
MFISH (24Cyte)Simultaneous investigation of all chromosomes |
Vysis AneuVysion Probe Set for Detection of AneuploidyChromosomes 13, 18, 21, X and Y |
Custom FISH ProbesFISH probes can be designed for most genes/regions of interest. This can be done for the same price as our routine FISH testing. Please enquire. |